Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,599 | 31,460 | 35,233 | 25,987 | 64,937 |
| Marketable Securities | 20,736 | 3,978 | 11,152 | 25,884 | 37,617 |
| Receivables | 1,335 | 2,422 | 35,834 | 34,108 | 163 |
| Inventories | 13,980 | 18,749 | 16,084 | 9,706 | 6,591 |
| Other current assets | 9,205 | 5,801 | 8,131 | 6,184 | 0 |
| TOTAL | $91,855 | $62,410 | $106,434 | $101,869 | $118,696 |
| Non-Current Assets | |||||
| PPE Net | 1,661 | 2,317 | 2,989 | 3,856 | 4,628 |
| Other Non-Current Assets | 49,190 | 52,557 | 55,849 | 59,779 | 65,464 |
| TOTAL | $50,851 | $54,874 | $58,838 | $63,635 | $70,092 |
| Total Assets | $142,706 | $117,284 | $165,272 | $165,504 | $188,788 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,146 | 5,253 | 2,854 | 3,684 | 6,511 |
| Accrued Expenses | 7,768 | 7,269 | 5,707 | 11,519 | 14,430 |
| Other current liabilities | 23,644 | 26,149 | 33,047 | 31,826 | 22,569 |
| TOTAL | $155,979 | $148,267 | $180,690 | $142,226 | $79,089 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 116,344 | 107,582 | 123,154 | 77,833 | 11,611 |
| Other Non-Current Liabilities | 76,796 | 79,318 | 82,171 | 84,947 | 86,608 |
| TOTAL | $77,266 | $79,885 | $82,890 | $122,509 | $160,537 |
| Total Liabilities | $233,245 | $228,152 | $263,580 | $264,735 | $239,626 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,760 | 4,915 | 4,817 | 4,774 | 4,077 |
| Common Shares | 1 | N/A | 12 | N/A | 10 |
| Retained earnings | -2,041,860 | -2,019,951 | -2,000,902 | -1,969,150 | -1,908,700 |
| Other shareholders' equity | 22 | -14 | -55 | -204 | -571 |
| TOTAL | $-90,539 | $-110,868 | $-98,308 | $-99,231 | $-50,838 |
| Total Liabilities And Equity | $142,706 | $117,284 | $165,272 | $165,504 | $188,788 |